A nthropic’s new Claude 4.5 just launched, and Anthropic claims it's the company's most powerful AI model yet. With the ...
Sarepta Therapeutics has followed through on its promise to file for accelerated approval of its gene therapy SRP-9001 for Duchenne muscular dystrophy (DMD), as it aims for a launch in the middle of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback